UA82532C2 - Спосіб виготовлення капсул флуконазолу з покращеним вивільненням - Google Patents

Спосіб виготовлення капсул флуконазолу з покращеним вивільненням Download PDF

Info

Publication number
UA82532C2
UA82532C2 UAA200600919A UAA200600919A UA82532C2 UA 82532 C2 UA82532 C2 UA 82532C2 UA A200600919 A UAA200600919 A UA A200600919A UA A200600919 A UAA200600919 A UA A200600919A UA 82532 C2 UA82532 C2 UA 82532C2
Authority
UA
Ukraine
Prior art keywords
capsules
fluconazole
particles
lactose
spraying
Prior art date
Application number
UAA200600919A
Other languages
English (en)
Russian (ru)
Ukrainian (uk)
Inventor
Паль Фекете
Джудит Виргула
Ева Фурдьюга
Хусар Магдолна Левентисне
Имре Клебович
Немеш Каталин Балогне
Original Assignee
Эгиш Дьедьсердьяр Рт.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эгиш Дьедьсердьяр Рт. filed Critical Эгиш Дьедьсердьяр Рт.
Publication of UA82532C2 publication Critical patent/UA82532C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
UAA200600919A 2003-07-02 2004-06-30 Спосіб виготовлення капсул флуконазолу з покращеним вивільненням UA82532C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0302030A HU227142B1 (en) 2003-07-02 2003-07-02 Capsule of improved release containing fluconazole
PCT/HU2004/000071 WO2005002553A2 (en) 2003-07-02 2004-06-30 Fluconazole capsules with improved release

Publications (1)

Publication Number Publication Date
UA82532C2 true UA82532C2 (uk) 2008-04-25

Family

ID=89981480

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200600919A UA82532C2 (uk) 2003-07-02 2004-06-30 Спосіб виготовлення капсул флуконазолу з покращеним вивільненням

Country Status (10)

Country Link
EP (1) EP1648451A2 (cs)
CN (1) CN1812783A (cs)
BG (1) BG109430A (cs)
CZ (1) CZ200657A3 (cs)
EA (1) EA008585B1 (cs)
HU (1) HU227142B1 (cs)
PL (1) PL380995A1 (cs)
SK (1) SK50132006A3 (cs)
UA (1) UA82532C2 (cs)
WO (1) WO2005002553A2 (cs)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE102004032049A1 (de) * 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
GB0900786D0 (en) * 2009-01-19 2009-03-04 Natracine Uk Ltd Therapeutic compositions
MD3971C2 (ro) * 2009-04-29 2010-06-30 Дмитрий СКУРТУ Scaun-trenajor
RS56528B1 (sr) 2011-07-29 2018-02-28 Gruenenthal Gmbh Tableta za trenutno oslobađanje leka rezistentna na zloupotrebu
AU2012292418B2 (en) 2011-07-29 2017-02-16 Grunenthal Gmbh Tamper-resistant tablet providing immediate drug release
CA2917136C (en) 2013-07-12 2022-05-31 Grunenthal Gmbh Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
CN105616378A (zh) * 2014-10-31 2016-06-01 康普药业股份有限公司 一种氟康唑胶囊及其制备方法
WO2017042325A1 (en) 2015-09-10 2017-03-16 Grünenthal GmbH Protecting oral overdose with abuse deterrent immediate release formulations
CN113230236A (zh) * 2021-04-29 2021-08-10 山东优杰生物科技有限公司 祛除灰指甲草本贴及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT75616A (en) * 1992-03-17 1997-05-28 Pfizer Method for prooucing porous delivery devices
US6214386B1 (en) * 1995-11-22 2001-04-10 Recordati, S.A. Prompt-release oral pharmaceutical compositions for extemporaneous suspensions
ES2251985T3 (es) * 1999-03-24 2006-05-16 R.P. Scherer Technologies, Inc. Particula granulada para mejorar la solubilidad acuosa de farmacos, y su procedimiento de preparacion.
KR100694667B1 (ko) * 1999-12-08 2007-03-14 동아제약주식회사 생체내이용률 향상과 개인간 및 개인내 흡수 편차를감소시킨 이트라코나졸 함유 항진균성 제제
RU2201230C1 (ru) * 2001-12-24 2003-03-27 Закрытое акционерное общество "Брынцалов-А" Лекарственное средство флузол, обладающее противогрибковым действием

Also Published As

Publication number Publication date
EP1648451A2 (en) 2006-04-26
WO2005002553A2 (en) 2005-01-13
PL380995A1 (pl) 2007-04-16
EA200600085A1 (ru) 2006-08-25
CN1812783A (zh) 2006-08-02
SK50132006A3 (sk) 2006-05-04
BG109430A (en) 2006-11-30
CZ200657A3 (cs) 2006-04-12
HUP0302030A2 (hu) 2005-03-29
EA008585B1 (ru) 2007-06-29
HU0302030D0 (en) 2003-09-29
HU227142B1 (en) 2010-08-30
WO2005002553A3 (en) 2005-03-24

Similar Documents

Publication Publication Date Title
Dobetti Fast-melting tablets: Developments and technologies
KR101352130B1 (ko) 디클로페낙 제제 및 이용 방법
TWI285116B (en) Drug delivery system for enhanced bioavailability of hydrophobic active ingredients
UA72922C2 (uk) ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ З <font face="Symbol">b</font>-КАРБОЛІНОМ (ВАРІАНТИ) ТА СПОСІБ ЛІКУВАННЯ СЕКСУАЛЬНОЇ ДИСФУНКЦІЇ
HUP0500509A2 (hu) Azonnali felszabadulást biztosító mikronizált gyógyászati és gyógytáp porok
KR950013752B1 (ko) 분무 건조된 아세트아미노펜의 치료용 분말, 이의 제조방법 및 이를 함유하는 약제학적 제형
CZ20022429A3 (cs) Glyburidová kompozice
BRPI0809282B1 (pt) material granular, material de partida para uma forma de dosagem, forma de dosagem, processo de compressão direta para preparar uma forma de dosagem, uso do material granular e processo para granular um pó de polímero
KR20010034573A (ko) 합성 천연 프로게스테론과 에스트라디올을 기초로 하는약학적 조성물과 그의 제조 방법
US9387172B2 (en) Solid dosage form comprising micronized cytisine and its production method
UA82532C2 (uk) Спосіб виготовлення капсул флуконазолу з покращеним вивільненням
KR100877628B1 (ko) 지용성 물질을 포함하는 과립형 물질 및 제조방법
JP2008019279A (ja) 医薬製剤の製造方法
WO2010001574A1 (ja) タムスロシン塩酸塩を含有する球形微粒子の製造方法
CA2275626C (en) Homogeneous preformulations containing high concentrations of steroids, for producing low-dose solid and semi-solid pharmaceutical preparations
RU2187307C1 (ru) Твердые стабильные лекарственные формы преднизолона
CN100420437C (zh) 磷酸川芎嗪缓释微丸及制备方法
Pranitha et al. Formulation and Evaluation of Mebeverine Hydrochloride Sustained Release Capsules by Pelletization Technique
MXPA04011796A (es) Unidades de dosificacion progestagenica.
Renthlei et al. Floating Drug Delivery System: An Outlook
RU2266106C1 (ru) Способ получения антимикробного средства
Dhanorkar et al. EFFECTIVE TREATMENT OF TYPE II DIABETES BY USING PELLETS MANUFACTURED BY EXTRUSION AND SPHERONIZATION TECHNIQUE
EP2409701A1 (en) Prasugrel granules with improved stability
WO2020020711A2 (en) Solid pharmaceutical cytisine composition
Diliprao Formulation and Evaluation of Orodispersible Tablets of Amlodipine Besilate